Agios Pharmaceuticals (AGIO) Net Margin (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted Net Margin of 712.22% for Q1 2026, down 31.63% on a QoQ basis from 541.09% in Q4 2025, and up 56518.0% year-over-year from N/an in Q1 2025.
Agios Pharmaceuticals (AGIO) Net Margin (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' Net Margin history runs 13 years deep, the most recent figure standing at 712.22% for Q1 2026.
- Quarterly Net Margin rose 56518.0% year-over-year to 712.22% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 743.7% (down 244325.0% YoY) and the FY2025 annual result came in at 764.01%, down 260994.0% from the prior year.
- Net Margin was 712.22% for Q1 2026 at Agios Pharmaceuticals, down from 541.09% in the prior quarter.
- Across five years, Net Margin topped out at 10574.69% in Q3 2024 and bottomed at 1551.83% in Q1 2023.
- A 4-year average of 204.57% and a median of 1181.16% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin surged 1180896 bps — and 2025, when it tumbled 1137774 bps.
- Agios Pharmaceuticals' Net Margin stood at 1350.7% in 2023, then jumped by 33 bps to 899.56% in 2024, then jumped by 40 bps to 541.09% in 2025, then slumped by 32 bps to 712.22% in 2026.
- Business Quant data shows AGIO's Net Margin at 712.22% in Q1 2026, 541.09% in Q4 2025, and 803.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -712.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -712.22% |
| Dec 31, 2025 | -541.09% |
| Sep 30, 2025 | -803.05% |
| Jun 30, 2025 | -1,059.55% |
| Mar 31, 2025 | -1,277.40% |
| Dec 31, 2024 | -899.56% |
| Sep 30, 2024 | 10,574.69% |
| Jun 30, 2024 | -1,282.59% |
| Mar 31, 2024 | -1,181.16% |
| Dec 31, 2023 | -1,350.70% |
| Sep 30, 2023 | -1,234.27% |
| Jun 30, 2023 | -1,340.73% |
| Mar 31, 2023 | -1,551.83% |
| Dec 31, 2020 | -29.78% |
| Sep 30, 2020 | -57.06% |
| Jun 30, 2020 | -24.05% |
| Mar 31, 2020 | 50.33% |
| Dec 31, 2019 | -300.93% |
| Sep 30, 2019 | -416.43% |
| Jun 30, 2019 | -431.22% |